Advertisement
Advertisement

HLVX

HLVX logo

HilleVax Inc

1.87
USD
-0.03
-1.58%
Dec 18, 15:59 UTC -5
Closed
...

HilleVax Inc Profile

About

HilleVax Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax Inc. is based in BOSTON.

Info & Links

CEO

Robert Hershberg,

Headquarters

321 HARRISON AVE, SUITE 500
BOSTON, MA 02118, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.hillevax.com

Auditor

Ernst & Young LLP

Share holders

30

Employees

90

HilleVax Inc Statistics

Valuation Measures

Market Capitalization2

93.14M

Enterprise Value

-10.62M

Enterprise Value/EBITDA(ttm)

0.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-67.27%

Return on Invested Capital(ttm)

-64.28%

Return on Assets(ttm)

-51.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-160.86M

Net Income Available to Common(ttm)

-150.28M

Diluted EPS(ttm)

-3.10

Share Statistics

Beta (5Y Monthly)

0.81

52-Week Change

-87.26%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

49.81M

Dividend Yield

0.00%

Float4

14.39M

% Held by Insiders

71.10%

% Held by Institutions

86.42%

Balance Sheet

Total Cash(mrq)

189.31M

Total Cash Per Share(mrq)

3.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.25%

Quick Ratio(mrq)

14.25%

Book Value Per Share(mrq)

3.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.83

Free Cash Flow(ytd)

-106.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement